B P Morgan Selected Research

B P Morgan Research Topics

Disease

5	Inflammation (Inflammations) 03/2010 - 01/2000
5	Arthritis (Polyarthritis) 09/2004 - 02/2000
4	Macular Degeneration (Age-Related Maculopathy) 01/2021 - 11/2008
4	Rheumatoid Arthritis 09/2004 - 11/2000
4	Hemolysis 07/2001 - 01/2000
3	Multiple Sclerosis 10/2012 - 11/2001
3	Demyelinating Diseases (Demyelinating Disease) 02/2010 - 08/2002
2	Infections 02/2012 - 01/2000
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 11/2008 - 07/2001
2	Myasthenia Gravis 11/2006 - 11/2006
2	Experimental Autoimmune Myasthenia Gravis (Autoimmune Experimental Myasthenia Gravis) 11/2006 - 11/2006
2	Neuromuscular Diseases (Neuromuscular Disease) 11/2006 - 11/2006
2	Glomerulonephritis 03/2004 - 08/2002
2	Synovitis 11/2000 - 02/2000
2	Experimental Arthritis 11/2000 - 01/2000
1	Acute Disease 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Atypical Hemolytic Uremic Syndrome 04/2010
1	Disease Progression 03/2010
1	Meningococcal Meningitis 09/2009
1	Meningitis 09/2009
1	Immune Complex Diseases (Immune Complex Disease) 11/2008
1	Reperfusion Injury 11/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 11/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 11/2008
1	Nephritis 11/2008
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2004
1	Encephalitis (Encephalitis, Rasmussen) 12/2004
1	Neoplasms (Cancer) 03/2004
1	Dementia (Dementias) 11/2002
1	Postpartum Thyroiditis (Thyroiditis, Postpartum) 03/2002
1	Chronic Progressive Multiple Sclerosis 11/2001
1	Proteinuria 09/2001
1	Membranous Glomerulonephritis (Membranous Nephropathy) 09/2001
1	Thrombosis (Thrombus) 07/2001
1	Necrosis 08/2000
1	Neurodegenerative Diseases (Neurodegenerative Disease) 08/2000
1	Hepatocellular Carcinoma (Hepatoma) 08/2000
1	Acute-Phase Reaction 08/2000
1	Joint Diseases (Joint Disease) 01/2000

Drug/Important Bio-Agent (IBA)

28	Complement System Proteins (Complement)IBA 01/2021 - 01/2000
7	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 08/2011 - 02/2000
6	Proteins (Proteins, Gene)FDA Link 06/2015 - 01/2000
3	Complement Receptors (Complement Receptor)IBA 06/2015 - 01/2000
3	Biomarkers (Surrogate Marker)IBA 01/2013 - 02/2009
3	AntigensIBA 09/2004 - 11/2000
2	Complement Factor H (Factor H)IBA 01/2013 - 04/2010
2	Monoclonal AntibodiesIBA 03/2010 - 09/2001
2	Indicators and Reagents (Reagents)IBA 11/2008 - 08/2002
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2006 - 11/2006
2	AutoantibodiesIBA 11/2006 - 11/2006
2	Anaphylatoxin C5a ReceptorIBA 12/2004 - 02/2000
2	A-factor (Streptomyces)IBA 11/2000 - 08/2000
1	Serine (L-Serine)FDA Link 01/2013
1	Retinal Pigments (Pigments, Visual)IBA 08/2011
1	Retinaldehyde (Retinal)IBA 03/2010
1	AcPhe(ornithine- Pro- cyclohexylamine- Trp- Arg)IBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	Immunoglobulins (Immunoglobulin)IBA 11/2001
1	Collagen Type II (Type II Collagen)IBA 10/2001
1	Low Density Lipoprotein Receptor-Related Protein-2IBA 09/2001
1	AntibodiesIBA 09/2001
1	cobra venom factorIBA 07/2001
1	Hemoglobins (Hemoglobin)IBA 07/2001
1	GlycolipidsIBA 07/2001
1	CytokinesIBA 08/2000
1	Interleukin-6 (Interleukin 6)IBA 08/2000
1	Glycophorins (Glycophorin C)IBA 01/2000
1	VenomsIBA 01/2000
1	Complement Inactivating AgentsIBA 01/2000
1	CD55 Antigens (Decay Accelerating Factor)IBA 01/2000

Therapy/Procedure

2	Therapeutics 08/2002 - 11/2000
1	Intravenous Administration 02/2000